Published in Eur J Neurosci on April 01, 2006
Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache (2007) 2.36
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain (2009) 1.24
Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res (2008) 1.20
Migraine: where and how does the pain originate? Exp Brain Res (2009) 1.06
Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. Headache (2009) 1.04
Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine. Headache (2008) 0.99
Effect of carbon dioxide on calcitonin gene-related peptide secretion from trigeminal neurons. Headache (2007) 0.96
Trigeminal ganglion neuron subtype-specific alterations of Ca(V)2.1 calcium current and excitability in a Cacna1a mouse model of migraine. J Physiol (2011) 0.95
Oestrogen increases nociception through ERK activation in the trigeminal ganglion: evidence for a peripheral mechanism of allodynia. Cephalalgia (2009) 0.92
CGRP and migraine: could PACAP play a role too? Neuropeptides (2013) 0.90
Headache-type adverse effects of NO donors: vasodilation and beyond. Br J Pharmacol (2010) 0.88
Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway. Br J Pharmacol (2015) 0.83
Nitric oxide-proton stimulation of trigeminal ganglion neurons increases mitogen-activated protein kinase and phosphatase expression in neurons and satellite glial cells. Neuroscience (2008) 0.82
PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells. Br J Pharmacol (2014) 0.82
Neurogenic inflammation: a study of rat trigeminal ganglion. J Headache Pain (2010) 0.82
Trigeminal Pain Molecules, Allodynia, and Photosensitivity Are Pharmacologically and Genetically Modulated in a Model of Traumatic Brain Injury. J Neurotrauma (2015) 0.79
Current advances in orthodontic pain. Int J Oral Sci (2016) 0.79
Understanding migraine: Potential role of neurogenic inflammation. Ann Indian Acad Neurol (2016) 0.78
Repression of calcitonin gene-related peptide expression in trigeminal neurons by a Theobroma cacao extract. J Ethnopharmacol (2007) 0.78
TRPA1 activation leads to neurogenic vasodilatation: involvement of reactive oxygen nitrogen species in addition to CGRP and NO. Br J Pharmacol (2016) 0.77
Activation of transient receptor potential ankyrin 1 induces CGRP release from spinal cord synaptosomes. Pharmacol Res Perspect (2015) 0.75
Characterization of a mouse model of headache. Pain (2016) 0.75
CGRP as a neuropeptide in migraine: lessons from mice. Br J Clin Pharmacol (2015) 0.75
The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain (2017) 0.75
Nitric oxide release from trigeminal satellite glial cells is attenuated by glial modulators and glutamate. Int J Physiol Pathophysiol Pharmacol (2013) 0.75
Endothelial Nitric Oxide Synthase and Angiotensin Converting Enzyme Gene Polymorphisms in Migraine Patients. Noro Psikiyatr Ars (2013) 0.75
The effect of 17β-estradiol on gene expression of calcitonin gene-related peptide and some pro-inflammatory mediators in peripheral blood mononuclear cells from patients with pure menstrual migraine. Iran J Basic Med Sci (2015) 0.75
Electroacupuncture at Fengchi (GB20) inhibits calcitonin gene-related peptide expression in the trigeminovascular system of a rat model of migraine. Neural Regen Res (2017) 0.75
Selective inhibition of trigeminovascular neurons by fremanezumab - a humanized monoclonal anti-CGRP antibody. J Neurosci (2017) 0.75
Mammalian MAP kinase signalling cascades. Nature (2001) 18.89
The MAPK signaling cascade. FASEB J (1995) 10.81
Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones. J Physiol (1987) 6.72
Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol (1999) 5.93
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med (2002) 4.86
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med (2004) 4.39
The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol (1997) 3.26
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol (1993) 3.07
Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev (1998) 2.98
Neurobiology of migraine. Nat Rev Neurosci (2003) 2.39
Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science (2003) 2.21
Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev (1997) 1.98
Migraine. Lancet (1998) 1.84
Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain (1994) 1.72
Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron (2001) 1.70
Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A (1986) 1.65
RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol (1996) 1.63
Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia (1996) 1.62
NO-dependent vasorelaxation is impaired after gene transfer of inducible NO-synthase. Arterioscler Thromb Vasc Biol (2001) 1.53
Neurobiology of nitric oxide. Crit Rev Neurobiol (1996) 1.35
Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain (2001) 1.29
Variation in serotonergic inhibition of calcium channel currents in four types of rat sensory neurons differentiated by membrane properties. J Neurophysiol (1995) 1.27
Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J Neurosci (1999) 1.27
Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology (1994) 1.25
Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci (2003) 1.24
Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport (1993) 1.22
Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain (1995) 1.19
Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J Neurosci (1994) 1.17
5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res (2001) 1.09
The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology (1993) 1.09
Neurogenic inflammation in the context of migraine. Microsc Res Tech (2001) 1.09
Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats. Eur J Neurosci (2001) 1.08
A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3'-kinase to Ras by redox stress. J Biol Chem (1998) 1.06
Cyclic AMP and phorbol esters separately induce growth inhibition, calcitonin secretion, and calcitonin gene transcription in cultured human medullary thyroid carcinoma. J Biol Chem (1986) 1.04
Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J Auton Nerv Syst (1998) 1.02
Involvement of increased excitatory amino acids and intracellular Ca2+ concentration in the spinal dorsal horn in an animal model of neuropathic pain. Pain (1996) 1.02
Origin and Co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat. Microsc Res Tech (2001) 1.00
Neurogenic model of migraine. Cephalalgia (1995) 0.98
Binding of upstream stimulatory factor and a cell-specific activator to the calcitonin/calcitonin gene-related peptide enhancer. J Biol Chem (1997) 0.98
Regulation of the calcitonin/calcitonin gene-related peptide gene by cell-specific synergy between helix-loop-helix and octamer-binding transcription factors. J Biol Chem (1993) 0.95
Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow. J Vasc Res (2003) 0.95
Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes. Diabetes (2000) 0.94
Differential regulation of mitogen-activated protein kinase-responsive genes by the duration of a calcium signal. Mol Endocrinol (2000) 0.92
Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from the spinal cord is mediated by nitric oxide but not by cyclic GMP. Brain Res (2000) 0.91
Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons. Brain Res (2004) 0.90
Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats. Neuroreport (2001) 0.88
Nitric oxide promotes intracellular calcium release from mitochondria in striatal neurons. FASEB J (2002) 0.87
Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat. Br J Pharmacol (2000) 0.86
Nitric oxide mechanisms in migraine. Pathol Biol (Paris) (2000) 0.86
Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer. Mol Endocrinol (1998) 0.84
Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation. J Neurosci (1997) 0.84
Nitric oxide stimulates growth hormone secretion in vitro through a calcium- and cyclic guanosine monophosphate-independent mechanism. Horm Res (1999) 0.83
The phosphatase inhibitor, okadaic acid, increases peptide release from rat sensory neurons in culture. Neurosci Lett (1994) 0.82
Trigeminal pain pathway: peripheral and central activation as experimental models of migraine. Funct Neurol (2001) 0.82
Nitric oxide (NO) stimulates gonadotropin secretion in vitro through a calcium-dependent, cGMP-independent mechanism. Neuroendocrinology (1998) 0.81
Migraine with aura after administration of sublingual nitroglycerin tablets. Headache (2001) 0.80
Delayed cardioprotection afforded by nitroglycerin is mediated by alpha-CGRP via activation of inducible nitric oxide synthase. Int J Cardiol (2004) 0.77
Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache (2007) 2.36
Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci (2007) 1.50
Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction. Stroke (2010) 1.48
Amylin acts in the central nervous system to increase sympathetic nerve activity. Endocrinology (2013) 1.47
Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons. J Neurochem (2005) 1.36
Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine. J Neurosci (2009) 1.30
Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci (2003) 1.24
Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res (2008) 1.20
Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation. Expert Rev Mol Med (2011) 1.13
Differential expression of connexins in trigeminal ganglion neurons and satellite glial cells in response to chronic or acute joint inflammation. Neuron Glia Biol (2009) 1.05
Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization. Mol Pain (2011) 1.04
Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. Headache (2009) 1.04
Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP. Neuropharmacology (2009) 1.04
Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice. J Pain (2009) 1.02
Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache (2006) 1.01
Calcitonin gene-related peptide: an update on the biology. Curr Opin Neurol (2009) 1.01
Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan. Headache (2009) 0.98
Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist. J Neurosci (2012) 0.98
CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice. J Clin Invest (2011) 0.95
Dominant negative dimerization of a mutant homeodomain protein in Axenfeld-Rieger syndrome. Mol Cell Biol (2003) 0.93
Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension. Hypertension (2010) 0.93
Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cells. Endocrinology (2005) 0.92
Light aversion in mice depends on nonimage-forming irradiance detection. Behav Neurosci (2010) 0.92
Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons. Brain Res (2004) 0.90
CGRP and migraine: could PACAP play a role too? Neuropeptides (2013) 0.90
Analysis of two translocation breakpoints and identification of a negative regulatory element in patients with Rieger's syndrome. Birth Defects Res A Clin Mol Teratol (2004) 0.90
New insights into the molecular actions of serotonergic antimigraine drugs. Pharmacol Ther (2002) 0.89
Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: findings from array analysis. Neurosci Lett (2010) 0.88
An unusual class of PITX2 mutations in Axenfeld-Rieger syndrome. Birth Defects Res A Clin Mol Teratol (2006) 0.88
Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice. Diabetes (2011) 0.86
Calcium receptor-induced serotonin secretion by parafollicular cells: role of phosphatidylinositol 3-kinase-dependent signal transduction pathways. J Neurosci (2003) 0.85
Dietary grape seed polyphenols repress neuron and glia activation in trigeminal ganglion and trigeminal nucleus caudalis. Mol Pain (2010) 0.85
Cocoa-enriched diets enhance expression of phosphatases and decrease expression of inflammatory molecules in trigeminal ganglion neurons. Brain Res (2010) 0.85
Cell-specific activation of the atrial natriuretic factor promoter by PITX2 and MEF2A. J Biol Chem (2004) 0.84
Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment. IDrugs (2007) 0.84
An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headache. Otolaryngol Head Neck Surg (2006) 0.83
Regulation of the cell-specific calcitonin/calcitonin gene-related peptide enhancer by USF and the Foxa2 forkhead protein. J Biol Chem (2004) 0.82
Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment. Mayo Clin Proc (2005) 0.82
NCS-1 inhibits insulin-stimulated GLUT4 translocation in 3T3L1 adipocytes through a phosphatidylinositol 4-kinase-dependent pathway. J Biol Chem (2002) 0.82
Control of the calcitonin gene-related peptide enhancer by upstream stimulatory factor in trigeminal ganglion neurons. J Biol Chem (2007) 0.80
Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia. Headache (2014) 0.80
Protein inhibitors of activated STAT (Pias1 and Piasy) differentially regulate pituitary homeobox 2 (PITX2) transcriptional activity. J Biol Chem (2013) 0.79
Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia. Cephalalgia (2011) 0.79
DHE repression of ATP-mediated sensitization of trigeminal ganglion neurons. Headache (2010) 0.79
Validation of a novel rat-holding device for studying heat- and mechanical-evoked trigeminal nocifensive behavioral responses. J Orofac Pain (2012) 0.79
Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen. Headache (2011) 0.78
Repression of calcitonin gene-related peptide expression in trigeminal neurons by a Theobroma cacao extract. J Ethnopharmacol (2007) 0.78
Ramping it up: RAMP1 and the implications for migraine. Pharmacogenomics (2007) 0.78
Prolonged Jaw Opening Promotes Nociception and Enhanced Cytokine Expression. J Oral Facial Pain Headache (2016) 0.76
CGRP receptor antagonists: A new frontier of anti-migraine medications. Drug Discov Today Ther Strateg (2006) 0.76
Inclusion of cocoa as a dietary supplement represses expression of inflammatory proteins in spinal trigeminal nucleus in response to chronic trigeminal nerve stimulation. Mol Nutr Food Res (2013) 0.75
Homeobox protein, Hmx3, in postnatally developing rat submandibular glands. J Histochem Cytochem (2003) 0.75
Central Role of Protein Kinase A in Promoting Trigeminal Nociception in an In Vivo Model of Temporomandibular Disorders. J Oral Facial Pain Headache (2017) 0.75
CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice. J Clin Invest (2015) 0.75
Duplicate publication. Otolaryngol Head Neck Surg (2006) 0.75